Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.

Lignende værker

• Long-term Benefits of Risk Factor Reduction in Takotsubo Cardiomyopathy.—A Comment on Khalighi et al. Entitled “Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction”, J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
  af: Ponamgi, Shiva P., et al.
  Udgivet: (2016)
• Reply to the Comment on: Marco Cirillo The Memory of the Heart. J. Cardiovasc. Dev. Dis. 2018, 5, 55
  af: Cirillo, Marco
  Udgivet: (2018)
• Comment on “The Memory of the Heart”, J. Cardiovasc. Dev. Dis. 2018, 5, 55
  af: Anderson, Robert H.
  Udgivet: (2018)
• Correction: Bhutani et al. Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update. <i>J. Cardiovasc. Dev. Dis.</i> 2025, <i>12</i>, 207
  af: Vasvi Bhutani, et al.
  Udgivet: (2025-06-01)
• Correction: Marsh et al. Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine. <i>J. Cardiovasc. Dev. Dis.</i> 2021, <i>8</i>, 52
  af: Spencer R. Marsh, et al.
  Udgivet: (2022-04-01)